Contraception in felids.
Contraceptives are used for reversible reproductive control in genetically valuable wild felids, as permanent reproductive control in generic wild felids, and as an economically practicable means to control feral cats. The progestin contraceptives, megestrol acetate, melengesterol acetate, medroxyprogesterone acetate, and levonorgestrol (administered orally, in implants, or as depot injections), are effective in preventing pregnancy. However, long-term use is associated with endometrial hyperplasia, endometrial cancer, and mammary cancer. Gonadotropin releasing hormone analogs or luteinizing hormone vaccines that achieve contraception by suppressing ovarian or testicular function, do not have the adverse health effects of progestins. However, reliable reversibility has not been demonstrated, and male secondary sex characteristics may be suppressed. Bisdiamines also inhibit spermatogenesis and lower circulating testosterone concentrations in treated male cats. Porcine zona pellucida vaccines are ineffective contraceptives in felids and may cause serious health problems when combined with some adjuvants. Because of the limited availability of non-progestin contraceptives and side effects associated with some agents, widespread application of contraception to felids has been curtailed. More non-steroidal methods of contraception should be tested in the future to provide alternatives for controlling reproduction in felids. Furthermore, all empirical information on contraceptive safety and efficacy should be assembled in a database to provide the knowledge needed by veterinarians and managers to determine benefits/risks of currently available contraceptives in felids, both domestic and wild.
Munson
Linda
L
Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, 1 Shields Ave., Davis, CA 95616, USA. lmunson@ucdavis.edu
D000818:Animals; D003267:Contraception / Q000379:methods / Q000662:veterinary*; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000009:adverse effects; D003272:Contraceptive Agents, Male; D045989:Felidae; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D008297:Male; D009277:Nandrolone / Q000008:administration & dosage / Q000031:analogs & derivatives; D011372:Progestins / Q000008:administration & dosage
D003271:Contraceptive Agents, Female; D003272:Contraceptive Agents, Male; D011372:Progestins; D007987:Gonadotropin-Releasing Hormone; D009277:Nandrolone; C100075:mibolerone